Ignite Creation Date:
2024-05-06 @ 3:12 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02226276
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-20
First Post:
2014-08-25
Brief Title:
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
Sponsor:
City of Hope Medical Center
Organization:
City of Hope Medical Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-07
Start Date Type:
None
Primary Completion Date:
2021-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-07
Completion Date Type:
ESTIMATED
First Submit Date:
2014-08-25
First Submit QC Date:
August 25 2014
Study First Post Date:
2014-08-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-07-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL